Showing results (131-140 of 257) with videos related to
Sort By:
Pageof 26
Nihon Sanka Fujinka Gakkai Zasshi|March 1, 1994
[Evaluation of the effects of vibro-acoustic stimulation test on the fetus during labor under epidural analgesia and evidence of its safety by way of auditory brainstem response]S Morikawa, J Ishikawa, H Matsubara, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cellsY Furukawa, J A DeCaprio, A Freedman, et al.Japanese Journal of Clinical Oncology|December 1, 1984
In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodiesH Nakamura, F Hirayama, Y Tatsumi, et al.International Journal of Oncology|May 17, 2011
Regulation of basophilic and erythroid-differentiation of a human chronic myelogenous leukemia-cell line, ku812f, by interleukin-3 and stem-cell factorH Kitayama, Y Kanakura, T Furitsu, et al.The American Journal of Pathology|January 1, 1996
Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell lineK Hashimoto, T Tsujimura, Y Moriyama, et al.Molecular and Cellular Biology|May 1, 1997
Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5I Matsumura, J Ishikawa, K Nakajima, et al.Gan No Rinsho. Japan Journal of Cancer Clinics|July 1, 1985
[Infectious complications and infection prevention in patients with acute leukemia]H Teshima, Y Kanakura, K Ishihara, et al.Blood|May 15, 1993
Mast cell number in the skin of heterozygotes reflects the molecular nature of c-kit mutationT Tsujimura, U Koshimizu, H Katoh, et al.American Journal of Hematology|November 14, 2000
Epstein-Barr virus associated B-cell lymphoma of brain developing in myelodysplastic syndrome with c-kit mutation (Try-557 -->stop)Y Kuwahara, A Hirata, H Miwa, et al.Blood|February 9, 1999
Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization siteT Tsujimura, K Hashimoto, H Kitayama, et al.Pageof 26